Jul 30, 2026 02:37AM
Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
Mar 2, 2026 06:01AM FDA accepts rusfertide application with priority review for blood disorder
Mar 2, 2026 02:00AM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 8, 2025 02:54AM Protagonist and Takeda report 52-week rusfertide data in polycythemia vera
Dec 6, 2025 09:30AM
Nov 21, 2025 11:54AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM Takeda partners with Innovent for $1.2 billion oncology deal
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
Jul 21, 2025 08:01AM
Jul 21, 2025 08:00AM
Jul 14, 2025 05:55AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM
Jun 3, 2025 10:12AM European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
Jun 1, 2025 08:00AM
May 21, 2025 09:32AM
May 14, 2025 05:10PM
May 14, 2025 05:03PM
May 5, 2025 08:00AM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Dec 3, 2024 07:00AM
Nov 7, 2024 07:00AM
Sep 24, 2024 03:00AM
Sep 19, 2024 08:00AM
Aug 7, 2024 06:45AM
Aug 7, 2024 06:45AM
Aug 6, 2024 04:01PM Ligand Reports Second Quarter 2024 Financial Results
Jun 22, 2024 10:30PM

327,050 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All